Pro-Dex Inc. Poised for Growth with Zimmer's mBos Robot Advancement
Long Cast Advisers' Q2 2026 letter highlights Pro-Dex, Inc. (PDEX) as a top contributor, projecting significant operational cash flow transformation from Zimmer's mBos robot commercialization. The analysis indicates that achieving CVR hurdles is feasible, suggesting a substantial increase in corporate value for Pro-Dex despite its absence from leading hedge fund portfolios. The firm maintains a patient investment strategy in small and micro-cap companies.
By Chika Uwazie